Results 141 to 150 of about 2,878 (233)
[Efficacy of chewing gum in post-cesarean ileus: A randomized clinical trial]. [PDF]
Cortes-Cernas VI +9 more
europepmc +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
[Annular Pancreas in Adults. A Case Report]. [PDF]
Marulanda Fernández H +2 more
europepmc +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Valoración del riesgo de náuseas y vómitos posoperatorios
Dilia Cobas Varona
doaj +4 more sources
[Prevalence of Rumination Syndrome: Experience in Three Countries of the Working Group on Brain-Gut Disorders of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)]. [PDF]
Velasco-Benítez CA +6 more
europepmc +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
Hemorraghic skin syndrome associated with contact of Lonomia spp. caterpillar: First report from the Ecuadorian Amazon [PDF]
Calvopina M +4 more
europepmc +1 more source

